Diagnosis, Prognosis, and Mechanisms in Panvascular Disease

Condition(s) studied

Investigational drug(s) / intervention(s)

No intervention: No intervention

Study summary

This study aims to establish a standardized cohort for panvascular diseases, encompassing biological materials such as DNA samples, along with extensive patient medical records and follow-up information. The design of this database will enable it to serve as a comprehensive resource for future medical research.

Upon data collection, researchers will conduct various statistical analyses to enhance our understanding of the factors and mechanisms contributing to various panvascular diseases, including coronary heart disease, myocardial infarction, stroke, and peripheral vascular disease. These statistical analyses will also aid in identifying more effective treatment strategies for these conditions.

By amassing a large volume of data from a significant number of patients with panvascular diseases, researchers will be able to perform highly precise analyses of the factors influencing the onset, progression, and treatment of these diseases. The results of these precise analyses can then be utilized to optimize clinical practices for the prevention and treatment of panvascular diseases.

Eligibility

Primary outcome measure(s)

• Number of participants with Cardiovascular mortality, Nonfatal myocardial Infarction, Ischemic stroke, Arteriosclerosis Obliterans — Up to 5 years from baseline
  Cardiovascular mortality, Nonfatal myocardial Infarction, Ischemic stroke, Arteriosclerosis Obliterans

Trial sites (1)

More Jinwei Tian trials in China

Other trials for the same condition